Recommendations for conducting invasive urodynamics for men with lower urinary tract symptoms: Qualitative interview findings from a large randomized controlled trial (UPSTREAM).


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
01 2019
Historique:
received: 30 03 2018
accepted: 10 09 2018
pubmed: 13 10 2018
medline: 11 2 2020
entrez: 13 10 2018
Statut: ppublish

Résumé

To capture in-depth qualitative evidence regarding attitudes to and experiences of urodynamic testing among men with lower urinary tract symptoms (LUTS) at each end of the clinical pathway. Semi-structured interview study conducted within the Urodynamics for Prostate Surgery: Randomized Evaluation of Assessment Methods (UPSTREAM) trial, which randomized men to a care pathway including urodynamics or routine non-invasive tests from 26 secondary care urology sites across England. Men were interviewed after assessments but prior to treatment, or after surgery for LUTS. Men were purposively sampled to include those who had urodynamics and those who did not, and diversity in demographic characteristics and symptom burden. Interviews were analyzed using inductive thematic analysis. Forty-one men participated (25 pre-treatment, 16 post-surgery), ages 52-89. The 16 men who had not previously experienced urodynamics said they would accept the test in their assessment, but some were apprehensive or wanted more information. The 25 men who had experienced urodynamics all found it acceptable, though some reported pain, infection, or embarrassment. Embarrassment was minimized by informing patients what the procedure would be like, and ensuring privacy. Urodynamics was valued for its perceived diagnostic insight. Information deficits were reported before, during, and after the test. How and when results were explained and the adequacy of explanations varied. Urodynamics is acceptable to men with LUTS and generally well-tolerated. To ensure patients are prepared and informed, good communication before and during the procedure is essential. Privacy should be prioritized, and test results discussed promptly and in sufficient detail. Staff require training and guidance in these areas.

Identifiants

pubmed: 30311686
doi: 10.1002/nau.23855
pmc: PMC6334271
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-329

Subventions

Organisme : Department of Health
ID : 12/140/01
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K025643/1
Pays : United Kingdom

Informations de copyright

© 2017 The Authors. Neurourology and Urodynamics Published by Wiley Periodicals, Inc.

Références

Neurourol Urodyn. 2006;25(7):674-83; discussion 684
pubmed: 17016795
Urology. 2015 Mar;85(3):547-51
pubmed: 25733264
J Obstet Gynaecol. 2002 Jan;22(1):48-50
pubmed: 12521729
Cochrane Database Syst Rev. 2015 Apr 28;(4):CD011179
pubmed: 25918922
Ann Acad Med Singap. 2004 Nov;33(6):754-7
pubmed: 15608833
Urology. 2005 Jul;66(1):74-6
pubmed: 15992874
J Urol. 2017 Feb;197(2S):S189-S197
pubmed: 28012747
J Urol. 1998 Jan;159(1):191-4
pubmed: 9400470
Neurourol Urodyn. 2016 Sep;35(7):805-8
pubmed: 26199116
J Adv Nurs. 2000 Dec;32(6):1356-63
pubmed: 11136403
Eur Urol. 2016 May;69(5):759-60
pubmed: 26847139
Scand J Urol Nephrol. 2006;40(5):391-6
pubmed: 17060086
BMJ. 2002 Oct 5;325(7367):766-70
pubmed: 12364308
J Urol. 2004 Jun;171(6 Pt 1):2307-10
pubmed: 15126810
BJU Int. 2009 Apr;103 Suppl 3:4-11
pubmed: 19302497
Eur Urol. 2015 Jun;67(6):1099-1109
pubmed: 25613154
Urology. 2000 Jul;56(1):37-9
pubmed: 10869618
Neurourol Urodyn. 2015 Feb;34(2):156-60
pubmed: 24259301
Trials. 2015 Dec 10;16:567
pubmed: 26651344
BJU Int. 2005 Dec;96(9):1307-9
pubmed: 16287450
Neurourol Urodyn. 2019 Jan;38(1):320-329
pubmed: 30311686
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Urol. 2005 Feb;173(2):555-9
pubmed: 15643252
Urol Int. 2011;87(3):314-8
pubmed: 21967837
Neurourol Urodyn. 2015 Jun;34(5):407-12
pubmed: 24853652

Auteurs

Lucy E Selman (LE)

Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.

Cynthia A Ochieng (CA)

Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.

Amanda L Lewis (AL)

Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Marcus J Drake (MJ)

Bristol Urological Institute, North Bristol NHS Trust, Level 3 Learning and Research Building, Bristol, UK.
Translational Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

Jeremy Horwood (J)

Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH